|
[1]KAPLAN GG,NG SC.Understanding and preventing the global increase of inflammatory bowel disease[J].Gastroenterology,2017,152(2):313-321.e2．
|
|
[2]WILSON JC,FURLANO RI,JICK SS,et al.Inflammatory bowel disease and the risk of autoimmune diseases[J].J Crohns Colitis,2016,10(2):186-193．
|
|
[3]VAVRICKA SR,FURLANO RI,JICK SS,et al.Extraintestinal manifestations of inflammatory bowel disease[J].Inflamm Bowel Dis,2015,21(8):1982-1992．
|
|
[4]ROTHFUSS KS,STANGE EF,HERRLINGER KR.Extraintestinal manifestations and complications in inflammatory bowel diseases[J].World J Gastroenterol,2006,12(30):4819-4831．
|
|
[5] HARBORD M,ANNESE V,VAVRICKA SR,et al.The first european evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease[J].J Crohns Colitis,2016,10(3):239-254．
|
|
[6]LEES CW,BARRETT JC,PARKES M,et al.New IBD genetics:Common pathways with other diseases[J].Gut,2011,60(12):1739-1753．
|
|
[7]HEDIN CRH,VAVRICKA SR,STAGG SJ,et al.The pathogenesis of extraintestinal manifestations:Implications for IBD research,diagnosis,and therapy[J].J Crohns Colitis,2019,13(5):541-554．
|
|
[8]SHAH SC,TEN HOVE JR,CASTANEDA D,et al.High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease[J].Clin Gastroenterol Hepatol,2018,16(7):1106-1113.e3．
|
|
[9]PENG T,LIU YL.Inflammatory bowel disease with myelodysplastic syndrome:An analysis of 9 cases and literature review[J].Chin J Intern Med,2010,49(11):967-968.(in Chinese)彭涛，刘玉兰．炎症性肠病合并骨髓增生异常综合征九例分析并文献复习[J]．中华内科杂志，2010,49(11):967-968．
|
|
[10]HAREWOOD GC,LOFTUS EV Jr,TEFFERI A,et al.Concurrent inflammatory bowel disease and myelodysplastic syndromes[J].Inflamm Bowel Dis,1999,5(2):98-103．
|
|
[11]FENG Y,LIU YL.Progress of the extraintestinal manifestations of inflammatory bowel disease[J].Chin J Gastroenterol Hepatol,2015,24(6):631-640.(in Chinese)冯云，刘玉兰．炎症性肠病的肠外表现的研究进展[J]．胃肠病学和肝病学杂志，2015,24(6):631-640．
|
|
[12]UEKI T,KAWAMOTO K,OTSUKA Y,et al.Prevalence and clinicopathological features of autoimmune pancreatitis in Japanese patients with inflammatory bowel disease[J].Pancreas,2015,44(3):434-440．
|
|
[13]HALLING ML,KJELDSEN J,KNUDSEN T,et al.Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases[J].World J Gastroenterol,2017,23(33):6137-6146．
|
|
[14]UHLIG HH,MUISE AM.Clinical genomics in inflammatory bowel disease[J].Trends Genet,2017,33(9):629-641．
|
|
[15]MCGOVERN DP,KUGATHASAN S,CHO JH.Genetics of inflammatory bowel diseases[J].Gastroenterology,2015,149(5):1163-1176.e2．
|
|
[16] LI J,WEI MM,FEI GJ,et al.The efficacy of cyclosporine A as salvage therapy for severe active ulcerative colitis refractory to glucocorticoid[J].Chin J Intern Med,2017,56(4):279-283.(in Chinese)李骥，韦明明，费贵军，等．环孢素A治疗糖皮质激素抵抗的重度溃疡性结肠炎疗效观察[J]．中华内科杂志，2017,56(4):279-283．
|
|
[17]WEISSMAN S,CHRIS-OLAIYA A,MEHTA TI,et al.A novel player:Cyclosporine therapy in the management of inflammatory bowel disease[J].Transl Gastroenterol Hepatol,2019,4:67.
|
DownLoad: